Cite
M49 - GENOME-WIDE ANALYSIS OF RISK-TAKING BEHAVIOUR IN 116 255 INDIVIDUALS FROM THE UK BIOBANK COHORT AND CROSS-DISORDER GENETIC CORRELATIONS.
MLA
Strawbridge, Rona, et al. “M49 - Genome-Wide Analysis of Risk-Taking Behaviour in 116 255 Individuals from the Uk Biobank Cohort and Cross-Disorder Genetic Correlations.” European Neuropsychopharmacology, vol. 29, Jan. 2019, pp. S981–82. EBSCOhost, https://doi.org/10.1016/j.euroneuro.2017.08.356.
APA
Strawbridge, R., Ward, J., Cullen, B., Tunbridge, E., Hartz, S., Bierut, L., Bailey, M., Graham, N., Ferguson, A., Lyall, D., Pidgeon, L., O’Donovan, M., Escott-Price, V., Harrison, P., & Smith, D. (2019). M49 - Genome-Wide Analysis of Risk-Taking Behaviour in 116 255 Individuals from the Uk Biobank Cohort and Cross-Disorder Genetic Correlations. European Neuropsychopharmacology, 29, S981–S982. https://doi.org/10.1016/j.euroneuro.2017.08.356
Chicago
Strawbridge, Rona, Joey Ward, Breda Cullen, Elizabeth Tunbridge, Sarah Hartz, Laura Bierut, Mark Bailey, et al. 2019. “M49 - Genome-Wide Analysis of Risk-Taking Behaviour in 116 255 Individuals from the Uk Biobank Cohort and Cross-Disorder Genetic Correlations.” European Neuropsychopharmacology 29 (January): S981–82. doi:10.1016/j.euroneuro.2017.08.356.